Ignite Creation Date:
2025-12-25 @ 4:09 AM
Ignite Modification Date:
2026-02-24 @ 4:46 PM
Study NCT ID:
NCT02404220
Status:
TERMINATED
Last Update Posted:
2020-01-02
First Post:
2015-03-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Entospletinib With Vincristine and Dexamethasone in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-05-06
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-17
Completion Date Type:
ACTUAL
First Submit Date:
2015-03-02
First Submit QC Date:
None
Study First Post Date:
2015-03-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-11-12
Results First Submit QC Date:
None
Results First Post Date:
2019-12-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-23
Last Update Post Date:
2020-01-02
Last Update Post Date Type:
ACTUAL